53 results
Page 2 of 3
424B5
lhvo6ns0v4
5 Mar 15
Prospectus supplement for primary offering
12:00am
424B2
s9gk1r2kcv2f7cy
13 Jun 14
Prospectus for primary offering
12:00am
F-3
g4ojl3p6oa1bbn ngxru
30 May 14
Shelf registration (foreign)
12:00am
424B5
rxlvyyhxgdst9p8 8tdb
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
hvhl6dwvptfdzo37f
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
mj5gi
8 Aug 13
Prospectus supplement
12:00am
424B5
pq5o73 a5by
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
vesmvu lb9q9
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-10.1
u7g xc5aeo5s
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
xyosmx5m
15 Oct 12
Prospectus supplement
12:00am
F-1
uc8 a7stgdwf89mx
2 Oct 12
Registration statement (foreign)
12:00am
6-K
9ha352mo2ta2pd86b
4 Sep 12
Current report (foreign)
12:00am
424B3
jltgy5s4f
2 Aug 12
Prospectus supplement
12:00am
POS AM
vt7imq8 61ea66
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
iku582x
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
6-K
EX-99.2
ke6gi
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-1
danpc
13 Oct 11
Current report (foreign)
12:00am